Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors

Oncology Reports

Volumn 26, Issue 6, 2011, Pages 1555-1560

  Yoshizawa, Kunio ^a   Nozaki, Shinichi ^b   Kitahara, Hiroko ^a   Kato, Koroku ^a   Noguchi, Natsuyo ^a   Kawashiri, Shuichi ^a   Yamamoto, Etsuhide ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KANAZAWA MEDICAL CENTER   (Japan)

Author keywords

Invasion; Maspin; Oral squamous cell carcinoma; Urokinase type plasminogen activator; Urokinase type plasminogen activator receptor

Indexed keywords

MASPIN; UROKINASE; UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER RISK; CANCER SURVIVAL; CELL DIFFERENTIATION; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUTH CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERPINS; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 80053525848     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1419     Document Type: Article

References (25)

1. Dass K, Ahmad A, Azmi AS, Sarkar SH and Sarkar FH: Evolving role of uPA/uPAR system in human cancers. Curr Cancer Ther Rev 34: 122-136, 2008.
2. Shi Z and Stack MS: Uninary-type plasminogen activator (uPA) and its receptor (uPAR) in squamous cell carcinoma of the oral cavity. Biochem J 407: 153-159, 2007. (Pubitemid 47556980)
3. Nowicki TS, Kummer NT, Iacob C, et al: Inhibition of uPAR and uPA reduces invasion in papillary thyroid carcinoma cells. Laryngoscope 120: 1383-1390, 2010.
4. Izuhara K, Ohta S, Kanaji S, Shiraishi H and Arima K: Recent progress in understanding the diversity of the human ov-serpin/ clade B serpin family. Cell Mol Life Sci 65: 2541-2553, 2008.
5. Amir S, Margaryan NV, Odero-Marah V, Khalkhali-Elis Z and Hendrix MJ: Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells. Cancer Biol Ther 4: 400-406, 2005. (Pubitemid 41357480)
6. Bailey CM, Khalkhale-Ellis Z, Seftor EA and Hendrix MJ: Biological functions of maspin. J Cell Physiol 209: 617-624, 2006. (Pubitemid 44665678)
7. Khalkhali-Ellis Z: Maspin: the new frontier. Clin Cancer Res 12: 7279-7283, 2006.
8. Biliran HJr and Sheng S: Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res 61: 8676-8682, 2001.
9. Yamamoto E, Miyakawa A and Kohama G: Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. Head Neck Surg 6: 938-947, 1984. (Pubitemid 14148096)
10. Nozaki S, Endo Y, Kawashiri S, et al: Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis. Oral Oncol 34: 58-62, 1998. (Pubitemid 28210532)
11. Kumamoto H and Ooya K: Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors. J Oral Pathol Med 36: 488-494, 2007. (Pubitemid 47222101)
12. Nozaki S, Endo Y, Nakahara H, et al: Inhibition of invasion and metastasis in oral cancer by targeting urokinase-type plasminogen activator. Oral Oncol 41: 971-977, 2005. (Pubitemid 41434063)
13. Conboy JG, Chan J, Mohandas N and Kan YW: Multiple protein 4.1 isoforms produced by alternative splicing in human erythroid cells. Proc Natl Acad Sci USA 85: 9062-9065, 1988. (Pubitemid 19001841)
14. Noguchi-Takino M, Endo Y, Yonemura Y and Sasaki T: Relationship between expression of plasminogen activator system and metastatic ability in human cancers. Int J Oncol 8: 97-105, 1996. (Pubitemid 26024140)
15. Gery S, Tanosaki S, Bose S, Bose N, Vadgama J and Koeffler HP: Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer. Clin Cancer Res 11: 3184-3190, 2005. (Pubitemid 40627863)
16. Yoshizawa K, Nozaki S, Okamune A, et al: Loss of maspin is negative factor for invasion and metastasis in oral squamous cell carcinoma. J Oral Pathol Med 38: 535-539, 2009.
17. Lonardo F, Li X, Siddiq F, et al: Maspin nuclear localization is linked to favorable morphological features in pulmonary adenocarcinoma. Lung Cancer 51: 31-39, 2006. (Pubitemid 43088622)
18. Marioni G, Gaio E, Giacomelli L, et al: Maspin subcellular localization and expression in oral cavity squamous cell carcinoma. Eur Arch Otorhinolaryngol 265: S97-S107, 2008.
19. Sood AK, Fletcher MS, Gruman LM, et al: The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 8: 2924-2932, 2002. (Pubitemid 35025740)
20. Xia W, Lau YK, Hu MC, et al: High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene 19: 2398-2403, 2000. (Pubitemid 30323472)
21. Yasumatsu R, Nakashima T, Hirakawa N, Kumamoto Y, Kuratomi Y, Tomita K and Komiyama S: Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head Neck 23: 962-966, 2001. (Pubitemid 32977539)
22. Taki M, Verschueren K, Yokoyama K, Nagayama M and Kamata N: Involvement of Ets-1 transcription factor in inducing matrix metalloproteinase-2 expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Int J Oncol 28: 487-496, 2006.
23. Zhang M, Maass N, Magit D and Sager R: Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Differ 8: 179-186, 1997. (Pubitemid 27068895)
24. Gilles C, Polette M, Birembaut P, Brünner N and Thompson EW: Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines. Clin Exp Metastasis 15: 519-526, 1997. (Pubitemid 27323901)
25. Wernert N, Gilles F, Fafeur V, et al: Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res 54: 5682-5688, 1994.